Royal Inland Hospital is a medical facility located in Kamloops, British Columbia serving a catchment area of 225,000 km².

There are 224 beds in Royal Inland Hospital.

During the past decade, Royal Inland Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Royal Inland Hospital" #1 sponsor was "Bayer" with 1 trials, followed by "Boehringer Ingelheim" with 1 trials sponsored, "Canadian Immunization Research Network" with 1 trials sponsored, "Ono Pharma USA Inc" with 1 trials sponsored and "Sunnybrook Health Sciences Centre" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Royal Inland Hospital" #1 collaborator was "AbbVie" with 1 trials as a collaborator, "Apotex Inc." with 1 trials as a collaborator, "Arch Biopartners Inc." with 1 trials as a collaborator, "BC Children's Hospital Research Institute" with 1 trials as a collaborator and "CHU de Quebec-Universite Laval" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Royal Inland Hospital" are "COVID-19" (2 trials), "Atrial Fibrillation" (1 trials), "Cerebrovascular Accident" (1 trials), "Covid-19" (1 trials) and "Myocardial Infarction" (1 trials). Many other conditions were trialed in "Royal Inland Hospital" in a lesser frequency.

Most popular intervention types in "Royal Inland Hospital" are "Drug" (4 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "0, 112 day schedule" (1 trials), "0, 28 day schedule" (1 trials), "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials) and "Artesunate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Royal Inland Hospital" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Royal Inland Hospital". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Royal Inland Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Royal Inland Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".